trial

Cognitive Effects of tDCS and tRNS in Schizophrenia

NCTId NCT06155786
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 36 (actual)
Sponsored by The National Brain Mapping Laboratory (NBML)
Primary completion 2023-11-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2023-01-01
Primary completion
2023-11-01
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS) active stimulatortranscranial random noise stimulation (tRNS)

Sponsors

The National Brain Mapping Laboratory (NBML)Lead Sponsor
Leibniz Research Centre for Working Environment and Human FactorsCollaborator
Payame Noor UniversityCollaborator
RWTH Aachen UniversityCollaborator

Sites

2 total
Tehran, IranZanjān, Iran

Facts & assertions

4 sourced
Enrollment
36
Phase
NA
Primary Completion Date
2023-11-01
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS) active stimulator
drug
transcranial random noise stimulation (tRNS)
drug
lead_sponsor
The National Brain Mapping Laboratory (NBML)
company
collaborator
Leibniz Research Centre for Working Environment and Human Factors
company
Payame Noor University
company
indication
Schizophrenia
indication
Cognitive Impairment
indication
Schizophrenia
indication